Acquired Brand CTK Biotech operates as a brand under the SSI Diagnostica Group, suggesting potential alignment opportunities with SSI’s broader IVD portfolio and existing distributor networks to cross-sell and expand product adoption.

Global Reach SSI Diagnostica Group serves 130+ countries with 60M+ diagnostic tests annually, indicating strong international distribution channels and potential for CTK Biotech products to scale through established markets and to leverage SSI’s multi-continent footprint.

Diagnostics Focus With dedicated disease focus areas in Gastric, Respiratory, Bloodborne, and general microbiology, there are clear cross-sell opportunities for CTK Biotech’s kits within SSI’s existing diagnostic segments.

Recent Partnerships Past collaborations, such as the MD Solutions partnership in 2020, highlight a receptiveness to channel and integration partnerships that can be leveraged to accelerate distribution and co-developed solutions.

Growth Signals Revenue is in the low millions, suggesting a ripe opportunity for strategic sales initiatives, channel expansion, and OEM/white-label collaborations within SSI’s scaled operations to uplift sales and market share.